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Abstract
Background: Diabetes mellitus is a frequent underlying comorbidity in patients with Staphylococcus aureus
endocarditis, and it represents a risk factor for complications and a negative outcome. The pathogenesis of
staphylococcal endocardial infections in diabetic hosts has been poorly characterized, and little is known about
S. aureus gene expression in endocardial vegetations.
Methods: We utilized a rat model of experimental S. aureus endocarditis to compare the pathogenesis of
staphylococcal infection in diabetic and nondiabetic hosts and to study the global S. aureus transcriptome in
endocardial vegetations in vivo.
Results: Diabetic rats had higher levels of bacteremia and larger endocardial vegetations than nondiabetic
control animals. Microarray analyses revealed that 61 S. aureus genes were upregulated in diabetic rats, and the
majority of these bacterial genes were involved in amino acid and carbohydrate metabolism. When bacterial
gene expression in vivo (diabetic or nondiabetic endocardial vegetations) was compared to in vitro growth
conditions, higher in vivo expression of genes encoding toxins and proteases was observed. Additionally, genes
involved in the production of adhesins, capsular polysaccharide, and siderophores, as well as in amino acid and
carbohydrate transport and metabolism, were upregulated in endocardial vegetations. To test the contribution
of selected upregulated genes to the pathogenesis of staphylococcal endocarditis, isogenic deletion mutants
were utilized. A mutant defective in production of the siderophore staphyloferrin B was attenuated in the
endocarditis model, whereas the virulence of a surface adhesin (ΔsdrCDE) mutant was similar to that of the
parental S. aureus strain.
Conclusions: Our results emphasize the relevance of diabetes mellitus as a risk factor for infectious endocarditis
and provide a basis for understanding gene expression during staphylococcal infections in vivo.
Background
Infective endocarditis is an invasive human disease with
an estimated incidence of 5 to 16 cases per 100,000
person-years [1,2] and an in-hospital mortality rate of
18% to 20% [3]. Staphylococcus aureus is the most fre-
quent etiologic agent of endocarditis in developed coun-
tries [1,3] and is associated with an aggressive disease
course, a poor outcome, and complications such as local
destruction of valve tissue, septic emboli, and persistent
bacteremia [3]. Antibiotic resistance is widespread among
clinical S. aureus isolates, and bacteremia due to
methicillin-resistant S. aureus (MRSA) often requires
the use of expensive or less effective antibiotics.
Risk factors for endocarditis include injection drug
use, prosthetic heart valves, structural heart defects, and
comorbidities, such as diabetes [2,4,5]. Among patients
with endocarditis, S. aureus is more frequently isolated
from individuals with diabetes than those with no dia-
betes [6]. Moreover, patients with diabetes have higher
mortality due to S. aureus endocarditis than patients
without diabetes [7]. Although defects in the immune
response to bacterial infections in patients with diabetes
have been postulated [8], the mechanism(s) behind the
increased susceptibility to invasive S. aureus infections
remain elusive.
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cated in the pathogenesis of endocarditis. Fibronectin-
binding protein A (FnBPA) and clumping factor A
(ClfA) mediate staphylococcal adherence to endothelial
cells [9,10]. Damage to cardiac valves results in exposure
of the subendothelial matrix and deposition of fibrin and
platelets at the site of endovascular injury. ClfA plays a
role in S. aureus binding to platelets - an interaction that
is critical to the induction of staphylococcal endocarditis
[11]. Staphylococci recovered from rabbit endocardial
vegetations are highly encapsulated [12]. Other factors
shown to play a role in the pathogenesis of endocarditis
include gene regulators such as sar and agr [13], alpha
toxin [14], the sortase enzyme SrtA [15], and the proline
permease PutP [16].
Although numerous studies have described in vivo
expression of selected staphylococcal genes [17,18]), few
have investigated overall patterns of bacterial gene
expression in an infected host. Analyses of global gene
expression patterns have focused primarily on in vitro
conditions, and few descriptions of the S. aureus tran-
scriptome during the course of an infection have been
reported [19,20]. The S. aureus transcriptional profile
during growth in broth culture correlates poorly with
gene expression in mammalian infections, and further
work to characterize S. aureus gene regulation in vivo is
necessary [21].
Our goal was to assess the impact of concurrent dia-
betes mellitus on the course of endocarditis in a well-
defined experimental infection model, to compare the
transcriptional profile of S. aureus in established endo-
cardial vegetations of diabetic and nondiabetic hosts
versus growth in vitro, and to study the role of genes
highly expressed in vivo as virulence factors in S. aureus
endocarditis.
Methods
Bacteria and culture conditions
To evaluate differences in endocarditis disease severity
and for microarray analyses, diabetic or nondiabetic rats
were challenged with the MRSA strain COL. To estab-
lish the role of selected genes in the pathogenesis of
S. aureus endocarditis, we utilized S. aureus strain Newman
and its isogenic mutants. Newman ΔsdrCDE [22] was
kindly provided by Dr Timothy Foster, and Newman
ΔsbnE [23] was generously provided by Dr David
Heinrichs. Staphylococci were cultivated in tryptic soy
broth (TSB) to the mid-logarithmic phase, washed in
phosphate-buffered saline (PBS), and diluted to yield
an inoculum of approximately 3 × 10
4 CFU/rat.
Rat endocarditis model
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
All animal experiments were approved by the Harvard
Medical School Standing Committee on Animals or by
the local authorities in Regensburg. Diabetes was in-
duced one day prior to surgery by injecting male
Sprague-Dawley rats (approximately 200 g; Charles
River Laboratories, Wilmington, MA, USA, and Sulzfeld,
Germany) in the tail vein with streptozotocin (60 mg/kg);
control rats received citrate buffer only [24]. Animals were
considered diabetic if blood glucose levels exceeded 250
mg/dl after 24 h.
The rat model of catheter-induced S. aureus endocar-
ditis was described previously [25]. Catheterized diabetic
or nondiabetic rats were challenged intravenously with
approximately 3 × 10
4 CFU S. aureus 48 h after surgery.
Heparinized blood was collected daily from each animal
by tail vein puncture and plated quantitatively. Surviving
rats were euthanized on day 3 after challenge. Catheter
tips (about 2 cm) were removed, sonicated in PBS, and
plated quantitatively. The kidneys, spleens, and aortic
valve vegetations were weighed, homogenized, and cul-
tured quantitatively. Homogenized vegetations were
pelleted, suspended in RNAprotect Bacteria Reagent
(Qiagen, Hilden, Germany) overnight at 4°C, and stored
at -80°C.
RNA isolation
Total RNA was prepared from homogenized vegetation
pellets from single animals after digestion with 4 mg/ml
proteinase K (Qiagen) for 30 min. S. aureus COL cells
were lysed with 0.5 ml zirconia silica beads (Fisher
Scientific, Waltham, MA, USA) in a dental amalgam-
ator, and RNA was purified with the RNeasy Mini kit
(Qiagen), treated with DNase I (Invitrogen, Grand Island,
NY), and stored at -80°C. RNA integrity and absence of
eukaryotic RNA were confirmed by denaturing gel electro-
phoresis. RNA from planktonic cultures was isolated from
bacteria harvested from mid-logarithmic (5 h) or stationary
phase (18 h) TSB cultures incubated at 37°C.
Microarray analysis
Amplification of 10 ng RNA samples using ExpressArt
Nanokits (Amsbio, Cambridge, MA) was performed
according to the manufacturer’s recommendations for
bacterial mRNA amplification, except that the final
transcription and labeling step was performed using
Enzo BioArray HighYield RNA Transcript Labeling
kits (Farmingdale, NY, USA) to incorporate biotinyl-
ated ribonucleotides into final RNA products. Each
biotinylated RNA sample (1 μg) was hybridized to
Affymetrix S. aureus GeneChips (Santa Clara, CA,
USA) following the manufacturer’s recommendations
for antisense prokaryotic arrays. GeneChips were
washed, stained, and scanned, as previously described
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logarithmic or stationary phase culture) was analyzed
in duplicate. GeneChip signal intensity values for each
qualifier were then normalized, averaged, and analyzed
using GeneSpring 6.2 software (Silicon Genetics, Redwood
City, CA, USA), as described [26]. Genes were considered
to be induced in a vegetation if they were determined to
be present by Affymetrix algorithms in the endocarditis
condition, and if they exhibited a greater than two-fold
increase in RNA titer (Student’s t-test; P ≤0.05) compared
to the corresponding planktonic growth condition. Genes
were considered downregulated in the vegetations if they
were present in either planktonic condition and had an
expression level less than 50% of that observed in the cor-
responding planktonic growth condition (Student’s t-test;
P ≤0.05). All GeneChip data have been deposited in the
National Center for Biotechnology Information (NCBI)
Gene Expression Omnibus (GEO) microarray repository
under accession number [GEO:GSE62390].
Quantitative PCR
cDNA was synthesized using the AffinityScript Multiple
Temperature cDNA Synthesis Kit (Agilent Technologies,
S a n t aC l a r a ,C A ,U S A ) ,5μl of hot-denatured DNA-
free RNA, and 100 pmol of random hexamer primers.
Products were precipitated in ethanol, resuspended in
diethylpyrocarbonate-water, and stored at -20°C. Quantifi-
cation was performed using a LightCycler 2.0 apparatus
(Roche Diagnostics, Mannheim, Germany) and Quanti-
Tect SYBR Green PCR Kits (Qiagen), using 2 μlo fc D N A
and 20 pmol of each primer. Primers (Additional file 1:
Table S1) were synthesized by Eurofins MWG (Ebersberg,
Germany).
Statistical analysis
Student’s t-tests were used to compare gene expression
data. Mann-Whitney U tests were performed to compare
quantitative culture data, and the log rank test was used
to compare survival distributions. A P-value of ≤0.05
was considered significant.
Results
Infective endocarditis was more severe in diabetic than
nondiabetic rats
To assess the impact of diabetes on the pathogenesis of
S. aureus endocarditis induced by strain COL, we com-
pared the infection in rats with streptozotocin-induced
diabetes to that of nondiabetic rats. All rats showed in-
creasing bacteremia levels from days 1 to 3 (Figure 1A).
Diabetic rats had significantly higher levels of bacteremia
than nondiabetic rats on days 2 and 3 after inoculation
(Figure 1A). Diabetic rats had larger endocardial
Figure 1 Endocarditis was more severe in diabetic rats than in nondiabetic rats. (A) Diabetic animals had significantly higher levels of
bacteremia on day 2 and day 3 after bacterial challenge. (B) Diabetic animals had larger vegetations, and (C) the vegetations were associated
with a significantly higher bacterial burden. (D) The bacterial burden in the kidneys, spleens, and catheters were not significantly different
between diabetic and nondiabetic rats.
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teria per vegetation (Figure 1C). We also observed
trends toward elevated bacterial burdens in kidneys,
spleens, and explanted catheters from diabetic rats
compared with nondiabetic rats (Figure 1D), although
these differences did not reach statistical significance.
Differential S. aureus gene expression in diabetic and
nondiabetic rats
We hypothesized that staphylococcal gene expression
might be influenced by hyperglycemia in the diabetic
host. Microarray analyses, however, indicated that overall
gene expression was similar between the two groups of
animals challenged with S. aureus COL. A total of 61 tran-
scripts were more highly expressed under diabetic in vivo
conditions (selected genes are presented in Table 1). Most
of these genes were associated with metabolic processes
such as amino acid and carbohydrate metabolism or cell
homeostasis. LightCycler analyses confirmed higher
expression of ATP synthase atpA (12.9 ±4.3 fold) and
glyceraldehyde dehydrogenase gapA (10.6 ±2.1 fold) in
vegetations from diabetic rats compared with nondia-
betic rats. Only two genes (SACOL1895 and a 102 bp
fragment, both with unknown functions) had signifi-
cantly lower expression in the vegetations of diabetic
compared with nondiabetic animals.
Table 1 List of selected genes differentially expressed in diabetic and nondiabetic vegetations
Gene Diabetic versus nondiabetic Gene product Functional group
acpS 2.6 holo-(acyl-carrier-protein) synthase Lipid transport and metabolism
alr 2.9 alanine racemase Cell wall/membrane biogenesis
argG 10.0 argininosuccinate synthase Amino acid transport and metabolism
argH 15.3 argininosuccinate lyase Amino acid transport and metabolism
atpA 3.8 ATP synthase F1, alpha subunit Energy production and conversion
atpE 2.4 ATP synthase F0, C subunit Energy production and conversion
atpH 3.3 ATP synthase F1, delta subunit Energy production and conversion
cap5F 2.5 capsular polysaccharide biosynthesis Cell wall/membrane biogenesis
cap5K 3.5 capsular polysaccharide biosynthesis Cell wall/membrane biogenesis
ccrB 2.0 cassette chromosome recombinase B
dnaE 2.6 DNA polymerase III, alpha subunit Nucleotide metabolism, replication, recombination
fabD 3.3 malonyl CoA-acyl carrier protein transacylase Lipid transport and metabolism
gapA 4.4 glyceraldehyde 3-P dehydrogenase Carbohydrate transport and metabolism
geh 2.3 glycerol ester hydrolase Miscellaneous
glpP 2.2 glycerol uptake operon regulatory protein Transcription, translation and post-translational modification
glyS 4.2 glycyl-tRNA synthetase Transcription, translation and post-translational modification
hemX 2.2 hemX protein Transcription, translation and post-translational mod.
infB 2.6 translation initiation factor IF-2 Transcription, translation and post-translational modification
kdpE 2.4 DNA-binding response regulator Regulatory
ligA 2.3 DNA ligase, NAD-dependent Nucleotide metabolism, replication, recombination
menD 2.1 carboxylic acid synthase Coenzyme transport and metabolism
moeA 3.4 molybdopterin biosynthesis, putative Coenzyme transport and metabolism
nrdF 2.7 ribonucleoside-diphosphate reductase 2 Nucleotide metabolism, replication, recombination
pls 3.7 plasmin-sensitive protein Virulence
recQ 2.8 ATP-dependent DNA helicase Nucleotide metabolism, replication, recombination
rexA 3.2 exonuclease Nucleotide metabolism, replication, recombination
ribD 2.7 riboflavin biosynthesis protein Coenzyme transport and metabolism
ribE 2.4 riboflavin synthase, alpha subunit Coenzyme transport and metabolism
ruvB 2.2 Holliday junction DNA helicase Nucleotide metabolism, replication, recombination
sasA 4.8 LPXTG cell wall surface protein Virulence
sirC 3.1 iron ABC transporter, permease protein Inorganic ion transport and metabolism
ureC 7.5 urease, alpha subunit Amino acid transport and metabolism
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vegetations
To compare S. aureus gene expression in vivo versus
in vitro, we isolated bacterial RNA from endocardial veg-
etations on day 3 post-challenge and from staphylococci
in the logarithmic or stationary growth phase. Overall
gene expression in diabetic and nondiabetic animals was
similar, but differences between in vivo and in vitro
growth conditions tended to be more pronounced in
vegetations from diabetic hosts (Table 2). Microarray
analyses revealed that 116 and 109 genes were more
highly expressed in vegetations from nondiabetic and
diabetic rats, respectively, compared with both plank-
tonic conditions; 98 and 103 genes were more highly
expressed in vivo compared with logarithmic phase cul-
tures only; and 81 and 65 genes were more highly
expressed in vivo compared with stationary phase cul-
tures only. Additionally, we observed that 223 and 152
genes had reduced expression under in vivo conditions
in nondiabetic and diabetic animals, respectively, com-
pared with both planktonic conditions; 208 and 199
genes had lower expression in vivo compared to loga-
rithmic phase cultures only; and 183 and 106 genes had
lower expression in vivo compared to stationary phase
cultures only. The largest group of genes differentially
expressed in vegetations was genes of unknown function
(hypothetical proteins). The next largest groups were
genes involved in transcription, translation, and post-
translational modification; amino acid transport and
metabolism; cell wall and membrane biogenesis; nu-
cleotide metabolism and replication; carbohydrate trans-
port and metabolism; and virulence or immune-evasion
mechanisms (Figure 2). Numerous virulence-associated
genes, such as toxins and proteases, were more highly
expressed in endocardial vegetations than in planktonic
cultures.
A selection of S. aureus genes differentially expressed in
endocardial vegetations compared to planktonic growth
conditions in vitro is presented in Table 2. Among the
virulence-associated upregulated genes were the alpha-,
delta-, and gamma-hemolysins and the bi-component
leukocidins LukS and LukF, which were more highly
expressed under in vivo conditions than in vitro conditions.
Likewise, genes encoding the metalloprotease aureolysin,
the serine proteases SplBCDE, and the staphylococcal
secretory antigen SsaA were all upregulated in vivo.
Staphylococcal enterotoxin B (seb) showed higher ex-
pression in vegetations and in stationary growth phase
compared with S. aureus in logarithmic growth phase.
Neither srtA (encoding sortase A) nor putP (proline
permease) showed differential expression in vivo.T h e
superoxide dismutase sodA was significantly downreg-
ulated in endocardial vegetations compared with both
in vitro conditions.
The capsule synthesis operon (cap5A to cap5J)w a s
more highly expressed in vegetations than in either
planktonic growth phases, whereas the dltABCD operon
(encoding enzymes mediating D-alanylation of teichoic
acids in the cell envelope) was downregulated in vivo
compared with in vitro. Regarding the S. aureus ica locus
that encodes poly-N-acetyl glucosamine, apparently COL
does not synthesize this surface-associated polymer since
it has a mutated icaC gene (SACOL2692). Most of the
other ica genes were not differentially expressed in vivo
and in vitro.
Among the staphylococcal surface proteins, clumping
factor A (ClfA) and B (ClfB) genes were more highly
expressed in vivo compared with logarithmic- or sta-
tionary growth-phase planktonic cultures, respectively.
Fibronectin-binding protein A was significantly upregu-
lated in the vegetations of nondiabetic rats. Genes
encoding the LPXTG-anchored proteins SdrC (a beta-
neurexin-binding protein) and SasF (associated with
resistance to linoleic acid) were upregulated in vivo
compared with both in vitro conditions. Of note, ex-
pression of both spa (encoding protein A) and pls (en-
coding a surface-associated plasmin-sensitive protein)
were significantly lower in vivo than in vitro.
Regarding iron acquisition, we observed high in vivo ex-
pression of the sbn operon-encoding proteins required for
the synthesis of the nonhydroxamate siderophore staphy-
loferrin B. SbnABDEGHI were significantly upregulated in
vegetations from diabetic animals compared with logarith-
mic and stationary phase planktonic cultures. The same
trend and magnitude of changes in expression were also
observed in nondiabetic vegetations, but were not consid-
ered statistically significant. In addition, sirB,p a r to ft h e
sirABC operon encoding transport of staphyloferrin B into
the bacterial cell [23,27], showed significant upregulation
in nondiabetic rats with endocarditis. Some of the genes
encoding the siderophore staphyloferrin A (SACOL2167,
SACOL2169, and SACOL2170 [28]) were upregulated in
endocardial vegetations (Table 2).
Several of the iron-regulated S. aureus genes were also
involved in transport. Among the Isd genes that mediate
heme uptake, only isdD (a heme ABC transporter) was
consistently upregulated in vivo and only versus logarith-
mic phase S. aureus. Other iron-regulated genes with
significantly higher expression in vivo included the oligo-
p e p t i d ep e r m e a s ea n dnorD genes of the opp1ABCDFnorD
operon [29]. Numerous genes encoding transporters were
highly expressed by S. aureus in endocardial vegetations.
The maltose transport (malEFK) genes were almost uni-
formly upregulated in vivo by staphylococci recovered from
infected vegetations of nondiabetic and diabetic rats. Simi-
larly, kdpAB genes encoding a potassium-transporting
ATPase were upregulated in diabetic vegetations compared
to both in vitro growth conditions. Other upregulated
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Gene Nondiabetic versus
logarithmic phase
Vegetation versus
stationary phase
Diabetic versus
logarimthic phase
Vegetation
versus
stationary
Gene product
Virulence-associated genes
hla SACOL1173 22.9 ns 17.5 ns alpha-hemolysin precursor
hld SACOL2022 38.5 ns 37.8 ns delta-hemolysin
hlgA SACOL2419 18.5 5.4 6.3 2.1 gamma-hemolysin, component A
hlgB SACOL2421 11.8 2.7 ns ns gamma hemolysin, component B
hlgC SACOL2422 16.5 2.4 ns ns gamma hemolysin, component C
lukF SACOL2004 11.1 18.7 4.9 8.1 leukocidin F subunit
lukS SACOL2006 11.9 14.7 6.4 8.0 leukocidin S subunit
nuc SACOL0860 ns ns 2.9 7.8 thermonuclease
seb SACOL0907 8.0 ns 4.1 ns staphylococcal enterotoxin B
splB SACOL1868 10.7 5.7 ns. ns serine protease
splC SACOL1867 ns ns 3.4 2.5 serine protease
splD SACOL1866 ns ns 3.8 2.9 serine protease
splE SACOL1865 28.4 11.6 16.9 7.5 serine protease
aur SACOL2659 3.3 2.4 2.2 ns zinc metalloproteinase aureolysin
clpB SACOL0979 ns ns 4.4 8.1 ATP-dependent protease
ssaA SACOL2581 5.7 13.1 2.6 5.1 staphylococcal secretory antigen;
staphyloxanthin biosynthesis protein
sodA SACOL1610 -5.7 -4.5 -5.7 -4.5 superoxide dismutase
Cell wall and capsule synthesis
cap5A SACOL0136 8.5 2.8 8.8 3.0 capsular polysaccharide biosynthesis
protein
cap5B SACOL0137 7.3 2.6 7.4 2.6 capsular polysaccharide biosynthesis
protein
cap5D SACOL0139 6.3 2.2 7.4 3.8 capsular polysaccharide biosynthesis
protein
cap5E SACOL0140 13.4 10.2 9.1 6.8 capsular polysaccharide biosynthesis
protein
cap5F SACOL0141 5.3 3.6 ns ns capsular polysaccharide biosynthesis
protein
cap5G SACOL0142 4.3 2.5 6.6 4.0 capsular polysaccharide biosynthesis
protein
cap5I SACOL0144 3.3 ns 4.1 2.3 capsular polysaccharide biosynthesis
protein
cap5J SACOL0145 ns ns 2.2 2.4 capsular polysaccharide biosynthesis
protein
dltA SACOL0935 -8.5 -2.9 -6.2 -2.1 D-alanine-ligase subunit 1
dltB SACOL0936 -10.8 -3.4 -9.5 -2.8 D-alanyl-lipoteichoic acid biosynthesis
protein
dltC SACOL0937 -4.9 ns -4.9 ns D-alanine-ligase subunit 2
dltD SACOL0938 -13.5 -3.5 -7.4 -2.0 D-alanine transfer protein
Surface proteins
clfA SACOL0856 5.8 ns 5.6 ns clumping factor A
clfB SACOL2652 ns ns ns 3.1 clumping factor B
fnbA SACOL2511 3.4 2.7 ns ns fibronectin-binding protein A
sasF SACOL2668 12.2 10.5 14.4 12.9 LPXTG cell wall surface anchor family
protein
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sdrC SACOL0519 12.3 8.7 8.6 6.5 Ser-Asp repeat protein
pls SACOL0050 -2.3 -3.3 ns -4.3 surface protein
sasA SACOL2676 ns -9.8 2.2 -4.2 LPXTG cell wall surface anchor family
protein
spa SACOL0095 -6.3 -4.9 -5.7 -4.5 immunoglobulin G-binding protein A
precursor
Iron uptake and iron-regulated genes
sbnA SACOL0112 ns ns 48.9 22.2 siderophore biosynthesis protein
sbnB SACOL0101 ns ns 25.9 19.7 siderophore biosynthesis protein
sbnD SACOL0103 ns ns 18.4 17.1 siderophore biosynthesis protein
sbnE SACOL0104 ns ns 23.0 18.4 siderophore biosynthesis protein
sbnG SACOL0106 ns ns 21.6 25.2 siderophore biosynthesis protein
sbnH SACOL0107 ns ns 15.4 16.8 siderophore biosynthesis protein
sbnI SACOL0108 ns ns 23.5 30.0 siderophore biosynthesis protein
sirR SACOL0691 2.3 ns ns ns iron-dependent repressor
sirB SACOL0098 2.9 ns ns ns iron compound ABC transporter,
permease
SACOL2167 ns ns 2.9 ns iron complex transport substrate-
binding protein
SACOL2169 4.4 ns 4.2 ns aerobactin biosynthesis protein
SACOL2170 ns ns 2.6 ns major facilitator transporter
Transport
isdD SACOL1142 3.1 ns 2.3 ns Heme ABC transporter
dapF SACOL2479 18.2 18.9 15.2 15.6 diaminopimelate epimerase family
protein
SACOL2478 9.2 9.4 7.8 8.3 conserved hypothetical protein
SACOL2477 17.6 12.8 20.9 15.1 conserved hypothetical protein
opp1A SACOL2476 18.1 11.1 10.8 13.9 peptide ABC transporter
opp1B SACOL2475 4.3 3.4 11.2 9.0 peptide ABC transporter, permease
opp1C SACOL2474 15.9 12.9 30.4 24.0 peptide ABC transporter, permease
opp1D SACOL2473 ns ns 8.0 7.3 peptide ABC transporter ATP-binding
protein
opp1F SACOL2472 ns ns 21.5 20.9 peptide ABC transporter ATP-binding
protein
norD SACOL2471 17.8 12.3 27.0 18.5 transporter, putative
epiG SACOL1871 2.4 ns 2.6 ns lantibiotic ABC transporter protein
epiE SACOL1872 4.2 ns 4.4 ns lantibiotic ABC transporter protein
epiF SACOL1873 5.5 ns 5.7 ns lantibiotic ABC transporter protein
malE SACOL0193 ns ns 3.1 2.5 maltose ABC transporter, maltose-
binding
malF SACOL0194 7.4 3.9 6.0 3.5 maltose ABC transporter, permease
protein
malK SACOL0192 14.7 14.7 6.2 6.8 maltose ABC transporter, ATP-binding
protein
opuD SACOL2176 2.0 2.4 ns ns osmoprotectant transporter, BCCT
family
tet38 SACOL0122 21.2 12.2 13.1 8.9 tetracycline-resistance protein, putative
ulaA SACOL0400 12.9 5.6 7.3 3.2 PTS system ascorbate-specific
transporter
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uhpT SACOL0200 125 29 78.1 18.1 sugar phosphate antiporter
kdpA SACOL2068 ns ns 8.5 15.0 potassium-transporting ATPase,
C subunit
kdpB SACOL2067 ns ns 9.0 13.3 potassium-transporting P-type ATPase,
B unit
norB SACOL1475 25.1 27.5 16.1 17.3 drug transporter, quinolone-resistance
protein
SACOL1476 24.8 22.4 18.7 18.6 transmembrane amino acid
transporter
ilvA SACOL1477 34.0 25.0 28.7 22.7 threonine dehydratase
ald SACOL1478 42.3 24.0 31.2 17.6 alanine dehydrogenase
mntH SACOL1114 -9.5 -6.3 -9.4 -6.3 Mn2+/Fe2+ transporter
SACOL1115 -3.9 -4.0 -4.3 -4.4 hypothetical protein
mntC SACOL0688 3.7 -5.8 3.5 -6.3 ABC transporter substrate-binding
protein
mntB SACOL0689 4.1 -5.7 4.5 -4.7 ABC transporter permease
mntA SACOL0690 8.5 -2.7 5.6 -4.4 ABC transporter ATP-binding protein
SACOL0157 -11.4 -12.0 -12.9 -12.8 conserved hypothetical protein
SACOL0158 -6.8 -15.2 -6.1 -13.4 ABC transporter, ATP-binding protein
SACOL0159 -6.9 -8.2 -5.0 -6.1 ABC transporter, permease protein
SACOL0160 -4.9 -7.1 -5.5 -7.9 conserved hypothetical protein
Metabolism
adhE SACOL0135 22.9 22.3 30.9 31.1 alcohol dehydrogenase,
iron-containing
ald SACOL1478 42.3 24.0 31.2 17.6 alanine dehydrogenase
arcB1 SACOL1181 ns ns 2.2 2.5 ornithine carbamoyltransferase
arcC SACOL1182 21.8 15.3 12.9 9.9 carbamate kinase
arcD SACOL1183 8.7 5.9 6.8 4.8 arginine/ornithine antiporter
arcA SACOL2657 12.4 12.2 8.4 8.5 arginine deiminase
arcB2 SACOL2656 6.4 7.6 4.6 5.3 ornithine carbamoyltransferase
arcD SACOL2655 30.1 43.5 27.6 43.1 arginine/ornithine antiporter
argG SACOL0963 ns ns 3.4 6.4 argininosuccinate synthase
argH SACOL0964 ns ns 5.4 13.3 argininosuccinate lyase
deoB SACOL0124 4.0 2.2 4.4 2.3 phosphopentomutase
deoD SACOL0121 7.1 7.8 8.9 10.0 purine nucleoside phosphorylase
gltA SACOL1742 6.9 -6.7 4.8 -9.4 citrate synthase
gntK SACOL2515 6.9 4.9 ns ns gluconokinase
ilvA SACOL1477 34.0 25.0 28.7 22.7 threonine dehydratase
nirB SACOL2398 21.8 19.6 12.8 11.9 nitrite reductase [NAD(P)H],
large subunit
nirD SACOL2397 8.1 6.1 4.7 3.9 nitrite reductase [NAD(P)H],
small subunit
pflA SACOL0205 94.7 125.7 116.5 157.6 pyruvate formate-lyase-activating
enzyme
pflB SACOL0204 44.7 46.9 59.9 65.6 formate acetyltransferase
rbsK SACOL0253 6.9 2.5 4.9 ns. ribokinase
SACOL2396 19.0 14.3 7.4 6.1 uroporphyrin-III C-methyl transferase
SACOL1476 24.8 22.4 18.7 18.6 amino acid permease
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port, and tet38 and norB, mediating drug resistance. Of
note, mntH (a Mn
2+/Fe
2+ transporter) was downregulated
in vivo compared with both planktonic conditions, whereas
the mntABC operon (involved in Mn
2+ uptake [30]) was
upregulated compared with logarithmic phase S. aureus
and downregulated compared with stationary phase cells. A
large uncharacterized transporter operon (SACOL2471-
2479) was upregulated in vivo, whereas the SACOL0157 to
SACOL0160 operon had significantly lower expression
levels in vegetations than in planktonic cultures.
Genes associated with metabolic pathways and more
highly expressed in vegetations were numerous and in-
cluded an alcohol dehydrogenase (adhE), nitrite reduc-
tase (nirBD), and genes implicated in arginine (argGH
and two arc operons) and pyruvate (pflAB) metabolism.
Transcription of a few staphylococcal regulatory genes
was enhanced in vivo. The transcriptional regulator GntR
showed higher expression in vivo in nondiabetic rats. By
contrast, genes encoding the staphylococcal accessory regu-
lator SarS, the iron-regulated repressor Fur, the regulators
VraR and VraS, and the transcriptional regulator AraC had
lower expression in vivo than in vitro (Table 2). The agr
locus did not show consistent changes in vivo and in vitro
(Table 2), although in diabetic rats the locus was upregu-
l a t e dc o m p a r e dw i t hin vitro logarithmic phase cultures.
Confirmation of upregulated genes in endocardial
vegetations by real-time PCR
We used quantitative PCR to confirm differential ex-
pression of selected genes in vivo. Genes were selected
based on upregulation in microarray analysis, being a
potential virulence factor, and not having been impli-
cated in the pathogenesis of endocarditis previously. In
vitro or in vivo expression of sbnC, sdrC, and splB was
thus quantified using the LightCycler real-time PCR sys-
tem. Although the magnitude of the differences in gene
expression varied, we observed an overall good correl-
ation between gene expression measured by microarray
and LightCycler. All three genes tested showed a trend
towards higher gene expression levels in vivo, but only
splB showed significantly higher gene expression in
endocardial vegetations compared with both planktonic
growth phases (60.4-fold upregulation versus logarithmic
growth phase, P <0.01; and 8.6-fold versus stationary
growth phase, P = 0.03). Expression levels of sbnC and
sdrC in endocardial vegetations were significantly higher
compared with logarithmic growth phase S. aureus
(502.3-fold for sbnC, P <0.01; and 25.1-fold for sdrC,
P <0.01).
Role of selected genes in the pathogenesis of S. aureus
endocarditis
To assess the contribution of selected genes preferen-
tially expressed in vivo to the pathogenesis of S. aureus
endocarditis, we performed virulence studies in the non-
diabetic rat endocarditis model. We chose genes that
had not previously been implicated as important in
endocarditis - the sbn locus (encoding staphyloferrin B)
and the sdrCDE locus (involved in fibrinogen-mediated
S. aureus adherence to platelets under in vitro shear flow
conditions [31]). Rats infected with Newman ΔsbnE
Table 2 Selected genes that were differentially expressed in endocardial vegetations (Continued)
Regulators
agrA SACOL2026 ns ns 4.8 ns accessory gene regulator protein A
agrC SACOL2025 -2.6 -3.3 4.5 -2.2 accessory gene regulator protein C
agrD SACOL2024 2.3 -4.0 5.2 ns accessory gene regulator protein D
gntR SACOL2516 5.0 4.1 ns ns gluconate operon transcriptional
repressor
purR SACOL0539 ns 2.3 ns ns pur operon repressor
rsbV SACOL2056 ns 3.6 ns 3.7 anti-anti-sigma factor RsbV
rsbW SACOL2055 ns 2.7 ns 3.0 anti-sigma B factor
sarA SACOL0672 ns 2.5 ns 2.1 transcriptional regulator
sarS SACOL0096 -14.7 -7.2 -8.7 -4.2 transcriptional regulator
sigB SACOL2054 ns ns ns 2.1 alternative sigma factor
fur SACOL1541 ns ns -2.1 -3.1 transcriptional regulator, Fur family
araC SACOL2378 -3.6 -2.7 ns ns transcriptional regulator, AraC family
tetR SACOL2374 ns ns -2.0 -2.4 transcriptional regulator, TetR family
vraR SACOL1942 -4.8 -3.2 -3.7 -2.5 DNA-binding response regulator
vraS SACOL1943 -4.3 -2.8 -3.3 -2.2 sensor histidine kinase
ns, difference not significant.
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late (Figure 3A; P = 0.047, log-rank analysis), and they
had lower bacteremia levels at all time points, although
the differences reached significance only on day 2 (P=
0.039; Figure 3B). Likewise, rats infected with strain
Newman experienced greater weight loss (P=0.002) than
rats infected with the sbnE mutant (Figure 3C). No signifi-
cant differences were observed in the bacterial burden in
kidneys (Figure 3D) or vegetations (Figure 3E) from rats
infected with Newman or the ΔsbnE mutant. By contrast,
rats infected with strain Newman or the ΔsdrCDE mutant
had similar survival times (not shown), bacteremia levels
(Additional file 1: Figure S1A), and weight loss (Additional
file 1: Figure S1B). Likewise, the bacterial burdens in the
kidneys (Additional file 1: Figure S1C) and endocardial
vegetations (Additional file 1: Figure S1D) were compar-
able for wild-type and ΔsdrCDE strains.
Discussion
Patients with diabetes have a higher risk of staphylococ-
cal infections than those without diabetes, and patients
with diabetes who develop S. aureus infective endocardi-
tis are likely to experience a poor outcome [2,5]. We
have demonstrated in an animal model of S. aureus
endocarditis that diabetes is associated with a more
severe disease course, as reflected by higher levels of
bacteremia and larger endocardial vegetations. We used
the vegetations recovered from infected rats on infection
day 3 to investigate the in vivo transcriptome of S. aur-
eus in the setting of an acute infection. This time point
allowed maximal recovery of organisms multiplying
within the host and allowed us to recover sufficient bac-
terial RNA for analysis.
Characterization of gene regulation and gene expression
under in vivo conditions is a prerequisite for alternative
Figure 2 Number of genes differentially expressed in endocardial vegetations from (A) nondiabetic and (B) diabetic rats. Absolute
number of genes down- (left) or upregulated (right) in endocardial vegetations compared with in vitro exponential (red bars), stationary (blue
bars), or both growth phases (black bars). The four groups with the highest number of genes more highly expressed in vivo were amino acid
transport and metabolism; carbohydrate transport and metabolism; virulence or immune evasion; and transcription, translation, and
posttranslational modification.
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drug targets and vaccination strategies. The S. aureus tran-
scriptome under in vivo conditions has not been well char-
acterized. Global S. aureus gene expression in vitro has
been investigated after in vitro exposure to microbicides
[32], in response to mild acid [33], during growth in
biofilm [34], in blood [35], and after phagocytosis [36].
Changes in S. aureus gene expression during early adapta-
tion to the mouse lung have been described [19], and Date
et al.r e c e n t l yr e p o r t e dg l o b a lS. aureus gene expression in
human abscesses and infected murine kidneys [20]. Our
study is the first description of the S. aureus transcriptome
during an established endocardial infection. We used rich
medium (TSB) as an in vitro comparator condition, al-
though minimal medium such as Roswell Park Memorial
Institute medium may better reflect iron-limited condi-
tions in vivo. The choice of TSB as the in vitro comparator
medium may explain some of the differences in gene ex-
pression reported (for example, iron-rich medium versus
iron-depleted in vivo conditions). However, one of the
aims of our study was to compare the gene expression pat-
tern observed in endocarditis vegetations to gene expres-
sion found during growth under standard laboratory
conditions. Our approach thus ensures comparability to
previously published in vitro data (including previous
microarray data, for example [26,36-38]). It also highlights
the important contribution of in vivo conditions (for
example, iron starvation) to S. aureus gene expression
during an infection. An additional limitation of our study
is the lack of a glucose-supplemented in vitro control arm.
However, the fact that we did not observe significant dif-
ferences in S. aureus virulence gene expression between
nondiabetic and diabetic rats makes this additional control
less important.
Figure 3 Comparative virulence of strain Newman and its isogenic sbnE deletion mutant. (A) Compared to rats infected with strain
Newman, rats infected with the sbnE mutant (defective in the synthesis of the siderophore staphyloferrin B lived significantly longer than rats
infected with the parental strain, (B) had significantly lower levels of bacteremia on day 2, and (C) lost significantly less weight 48 h after bacterial
inoculation. (D) Bacterial burdens in the kidneys and (E) vegetations were not significantly different between wild-type and mutant strain.
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strain, which we used for the experiments with diabetic
versus nondiabetic rats and the microarray analyses.
Moreover, all gene expression studies and subsequent
analyses were performed with strain COL. A related
methicillin-sensitive S. aureus strain (Newman [39]) was
used for the single gene knockout studies because of the
availability of relevant mutant strains. Mutations in
strains Newman and COL have been described [40-42],
and both strains are members of clonal complex 8 and
readily produce endocarditis in rats.
We observed that more than 100 genes were upreg-
ulated in endocardial vegetations compared with
in vitro cultures. However, the number of genes sig-
nificantly downregulated in vivo was approximately
two-fold higher than the number of genes upregulated
in vivo. This may be because in vivo S. aureus gene ex-
pression was analyzed from vegetations three days
after bacterial challenge. Date et al. [20] reported
similar gene expression patterns in human abscesses
and infected murine kidneys for some S. aureus genes,
such as the serine proteases spl, gamma-hemolysin,
and the opp1 operon. Other genes with higher expres-
sion levels in abscesses, such as the isd genes, how-
ever, were not differentially expressed in endocardial
vegetations in our study.
A majority of the genes that were differentially
expressed in endocardial vegetations have not yet been
assigned a function or are classified as hypothetical pro-
teins. ClfA is a critical virulence factor in S. aureus
endocarditis [10] and clfA transcript levels have been re-
ported to increase after the late logarithmic growth
phase in vitro [43]. In our study, clfA was upregulated
in vivo versus logarithmic growth phase cells, whereas
fibronectin-binding protein A was found to be signifi-
cantly upregulated in nondiabetic vegetations only. Both
are likely to be critical for initiation of infection, as has
been described in previous studies [44,45]. Although
acapsular strains provoke endocarditis at lower inocula
than encapsulated isolates [46], S. aureus recovered from
vegetations produce large quantities of capsular polysac-
charides [12], consistent with our observation that the
cap5 genes were upregulated in established vegetations.
Capsule production enhances bacteremia in vivo and
renders the bacterium resistant to uptake and killing
by neutrophils [47]. Moreover, active and/or passive
immunization strategies targeting capsular polysaccha-
rides were able to protect rodents against S. aureus
bacteremia [48] and endocarditis [25]. In contrast to the
cap5 genes, the dlt operon was downregulated in endo-
cardial vegetations. The dlt genes encode proteins medi-
ating D-alanylation of lipoteichoic and wall teichoic
acids, and transcription of the dlt genes is repressed in
the presence of cations such as magnesium salt [49].
Higher dlt expression has been associated with dapto-
mycin resistance [50], and the observation that dlt is
downregulated in endocardial vegetations could thus
support clinical and preclinical data on the use of dapto-
mycin in staphylococcal endocarditis [51,52].
Other virulence factors upregulated in vivo include
exotoxins (hemolysins and leukotoxins) and proteases.
The serine protease genes splA to splE are located on a
pathogenicity island [39], and these proteases play a role
in the degradation and inactivation of antibacterial peptides
[53]. Both Spl proteases and aureolysin (aur) are associated
with detachment of S. aureus from established biofilms [54]
and may promote bacteremia by dispersing staphylococci
from endocardial vegetations. Exotoxins upregulated in
endocardial vegetations include two-component pore-
forming cytolysins such as gamma-hemolysin and LukFS
that are able to lyse erythrocytes and leukocytes [55]. Other
factors previously implicated in the pathogenesis of endo-
carditis, such as SrtA [15] and PutP [16], were not differen-
tially expressed in endocardial vegetations compared with
planktonic conditions.
To acquire iron from the host organism, S. aureus syn-
thesizes two major nonhydroxamate siderophores (sta-
phyloferrin A and staphyloferrin B [28,56]), as well as
proteins that mediate the import and utilization of iron
bound to heme or transferrin [57]. Although heme was
identified as a preferred iron source for S. aureus [57],
we found that genes for neither the iron surface deter-
minant (isd) nor the heme transport system (hts) were
significantly upregulated in endocardial vegetations
(with the exception of isdD compared with exponen-
tial phase cultures). By contrast, the staphyloferrin B
synthesis operon (sbnA to sbnI) was preferentially
upregulated in vivo. There was also a trend towards
higher expression in vivo of the fhuCBG operon en-
coding an ABC transporter for iron(III)-hydroxamates
[58]. However, fhuD1 and fhuD2, encoding iron(III)-
hydroxamate-binding lipoproteins, were not upregulated
in endocarditis (not shown). The observed differences
in iron uptake systems may in part be attributable to dif-
ferent experimental conditions and the animal models
employed (for example [59]).
Dale et al. [23] constructed a Newman mutant (ΔsbnE)
deficient in staphyloferrin B synthesis, and introduction
of sbnE on a plasmid complemented the inability of the
mutant to produce the siderophore under iron-limiting
conditions. The Newman ΔsbnE mutant was compro-
mised in the S. aureus renal abscess model [23]. This
mutant was attenuated in the endocarditis model be-
cause rats inoculated with the mutant showed lower
bacteremia levels, reduced weight loss, and increased
survival compared with animals challenged with the par-
ental strain. Although the reduction in virulence was
modest, this can likely be attributed to the multitude of
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staphylococcal endocarditis. Thus, staphyloferrin B ap-
pears to promote staphylococcal virulence in abscesses
and endocarditis.
Genes encoding multiple transporters were highly
expressed in endocardial vegetations, including amino
acid permeases, the lantibiotic transporter proteins
EpiEFG, a maltose transporter, a potassium ATPase,
the norD-opp1 operon, and genes associated with drug
resistance, such as tet38 and norB.N o r Bp r o m o t e d
bacterial survival in a subcutaneous abscess model
[17], and has broad substrate specificity. Upregulation
of norB under conditions of low pH or reduced aer-
ation has been reported [60]. Similarly, the efflux
pump transporter NorD is iron-regulated and highly
expressed in staphylococcal abscesses [29]. NorD is
part of an operon with five upstream oligopeptide per-
mease genes (opp1ABCDF), and all were significantly
upregulated in endocardial vegetations. NorB and
NorD efflux pumps may eliminate toxic metabolites or
antibacterial factors produced by the host in vivo,
although their substrates remain to be defined.
Among the surface molecules with higher expression
in endocardial vegetations were the LPXTG-containing
protein SasF, and the β-neurexin-binding protein SdrC.
Genes within the sdr region (sdrCDE) have been re-
ported to be differentially transcribed [61], and sdr genes
other than sdrC were not upregulated in endocardial
vegetations. SdrC could mediate initial contact with host
cells or cell adhesion molecules, such as β-neurexin [62],
although our experimental endocarditis data indicate
that it was not critical for the establishment of endocar-
ditis. SdrC may play a role in complications of infectious
endocarditis, such as metastatic seeding to neuronal
tissues.
The largest group of genes differentially expressed
in vivo were involved in amino acid transport and me-
tabolism. The chromosomal arginine deiminase pathway
(arcABCD) was strongly upregulated in endocardial
vegetations. Arginine metabolism may serve to counter
acidification or as an energy source under anaerobic
conditions [63]. The latter is supported by the fact that
nitrate reductase (NirBD) and pyruvate formate lyase
(PflAB [64]) were also upregulated in endocardial vege-
tations. Expression of the superoxide dismutase gene
sodA, which is induced under microaerophilic conditions
[65], was reduced in endocardial vegetations. Although
staphylococcal vegetations grow in the oxygen-rich
bloodstream at the aortic valve, the microenvironment
within the vegetation may be oxygen-starved. Of note,
we also observed differential gene expression of several
gene clusters with yet unknown function (for example,
upregulation of SACOL2477 to SACOL2479 and down-
regulation of SACOL0157 to SACOL0160 in endocardial
vegetations). Their role in staphylococcal infections and
contribution to the pathogenesis of endocarditis in par-
ticular remains to be determined.
S. aureus gene expression is controlled by a complex
network of regulatory proteins. In a previous study, ex-
pression of S. aureus agr in rabbit endocardial vegeta-
tions was shown to increase over time and to correlate
with bacterial densities in vegetations [66]. We observed
that the agr operon was only consistently upregulated in
endocardial vegetations, compared to cultures harvested
from the logarithmic growth phase, in diabetic rats. The
S. aureus fur regulator, which represses genes involved
in iron acquisition, cytolysins, and immunomodulatory
proteins [67], also had lower expression in endocardial
vegetations than in vitro, as did the transcriptional regu-
lator sarS. Differential expression of other regulatory
genes included downregulation of vraSR (involved in re-
sistance to cell wall active antibiotics and antimicrobial
peptides [68]) and the araC family regulator (linking en-
vironmental chemical signals and virulence factors [69]),
and upregulation of the gluconate repressor operon
gntR. The saeS gene was significantly downregulated
in vivo in the vegetations of diabetic rats.
With regard to genes differentially expressed in endo-
cardial vegetations from diabetic and nondiabetic rats,
we found 61 genes with higher expression levels in vege-
tations from diabetic animals. Although bacterial dens-
ities in the vegetations from both groups were similar
(not shown), vegetations from diabetic animals were sig-
nificantly larger and contained more bacteria than their
nondiabetic counterparts. The composition or size of
these vegetations may have an influence on staphylococ-
cal gene expression in endocarditis. Of note, several of
the differentially expressed genes with high upregulation
(argG, argH, glyS, ureC) were previously reported to be
upregulated in biofilms versus planktonic cultures [26].
Other genes found to be upregulated in diabetic vegeta-
tions (gapA, hemX, nrdF) were demonstrated to be under
the control of glucose and CcpA [70]. In summary, we
cannot exclude that differences in gene expression ob-
served between diabetic and nondiabetic rats with endo-
carditis reflect differences in the size of the vegetations
involved (possibly attributable to an altered innate immune
response in diabetic hosts). However, there is also evidence
that S. aureus may sense (and possibly benefit from) in-
creased glucose levels in hosts with diabetes mellitus.
Conclusions
We have demonstrated that diabetes mellitus leads to
higher bacterial burdens in an experimental model of S.
aureus endocarditis. Gene expression patterns in endo-
cardial vegetations differed from those observed during
in vitro growth, with overall downregulation of transcrip-
tion. Endocarditis promoted higher expression of genes
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in capsule biosynthesis, iron homeostasis, and glucose and
amino acid metabolism. Our findings indicate that gene
expression of the staphyloferrin B operon is upregulated
in endocarditis, and that production of this siderophore
promoted staphylococcal virulence in this infection model.
These results may form a basis for future analyses of spe-
cific genes, regulators, and pathways that are critical in
endocarditis and other infections. Our findings may thus
contribute to a better understanding of S. aureus patho-
genesis in vivo and lead to alternative approaches in pre-
vention or treatment of staphylococcal endocarditis.
Additional file
Additional file 1: Figure S1. Comparative virulence of strain Newman
and its isogenic sdrCDE deletion mutant. (A) Infection with the mutant
strain led to comparable levels of bacteremia, (B) weight loss at 48 h,
(C) bacterial burden in the kidneys and (D) endocardial vegetations
compared to infection with the parental strain. Table S1. Primers used
for real-time PCR.
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